Triple combination of irinotecan + oxaliplatin + 5-fluorouracil as first-line chemotherapy for metastatic colorectal cancer: first experience with a new treatment regimen

Por A. D. Darenskaya, N. V. Dobrova
Publicado em 2018-05-01

Results of using 3-component regimen TEGOXIRI (tegafur, oxaliplatin, irinotecan) ± Leucovorin in patients with advanced colorectal cancer

Por N. V. Dobrova, A. D. Darenskaya
Publicado em 2019-12-01

Prognostic value of Bax expression in the primary colon tumor of patients with metastatic colorectal cancer receiving first-line treatment with a triple combination of irinotecan +...

Por A. D. Darenskaya, N. V. Dobrova, E. V. Stepanova
Publicado em 2019-06-01

Bax protein as a prognostic marker in colorectal cancer: characteristics, role in apoptosis regulation, and correlation with disease prognosis (literature review)

Por A. D. Darenskaya, N. V. Dobrova, E. V. Stepanova
Publicado em 2019-06-01

Impact of topoisomerase IIα overexpression in the primary colon tumor on the prognosis of metastatic colorectal cancer

Por A. D. Darenskaya, N. V. Dobrova, E. V. Stepanova
Publicado em 2018-11-01

Cetuximab in treatment of metastatic colorectal cancer: background and clinical observation

Por A. D. Darenskaya, N. V. Dobrova, B. M. Medvedeva
Publicado em 2018-11-01

Results of using tegafur in combination with irinotecan and oxaliplatin in patients with advanced colorectal cancer

Por N. V. Dobrova, E. I. Borisova, A. D. Darenskaya
Publicado em 2018-11-01

Second line anti-cancer therapy for metastatic colorectal cancer: treatment strategy

Por K. A. Vorontsova, N. V. Dobrova, G. V. Vyshinskaya
Publicado em 2015-12-01

FTORAFUR IN COMBINATION WITH OXALIPLATIN AND IRINOTECAN IN PATIENTS WITH DISSEMINATED COLORECTAL CANCER: PRELIMINARY RESULTS

Por N. V. Dobrova, E. A. Aratyunyan, I. N. Polushkina, V. A. Aliev
Publicado em 2018-02-01

CHEMOTHERAPY IN THE MANAGEMENT OF LOCALIZED AND METASTATIC COLON CANCER: NEW AND YET UNFORGOTTEN APPROACHES

Por N. V. Dobrova, O. O. Gordeeva, E. V. Chernoglazova, A. A. Tryakin
Publicado em 2017-11-01

Nab-paclitaxel in the treatment of breast cancer: clinical trial data and first-hand experience

Por E. I. Borisova, S. P. Gutorov, G. V. Vyshinskaya, N. V. Dobrova, M. E. Abramov
Publicado em 2018-11-01

INTEGRATION OF BEVACIZUMAB IN METASTATIC COLORECTAL CANCER CHEMOTHERAPY REGIMENS IN 2 CLINICAL CENTERS IN MOSCOW AND SAINT PETERSBURG

Por N. V. Dobrova, N. N. Semenov, G. M. Manikhas, N. Yu. Antimonik, Yu. V. Vakhabova, S. L. Gutorov
Publicado em 2015-02-01